Current Drug Metabolism
Title:Editorial [Hot Topic Lipohepatotoxicity and Nonalcoholic Steatohepatitis (NASH)-Like Metabolic Disorders (Guest Editor: Mustapha Cherkaoui-Malki)]
Volume: 13 Issue: 10
Author(s): Mustapha Cherkaoui-Malki
Affiliation:
Export Options
About this article
Cite this article as:
Cherkaoui-Malki Mustapha, Editorial [Hot Topic Lipohepatotoxicity and Nonalcoholic Steatohepatitis (NASH)-Like Metabolic Disorders (Guest Editor: Mustapha Cherkaoui-Malki)], Current Drug Metabolism 2012; 13 (10) . https://dx.doi.org/10.2174/138920012803762774
DOI https://dx.doi.org/10.2174/138920012803762774 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets Biodegradable Nanoparticles: A Recent Approach and Applications
Current Drug Targets A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking
Current Drug Abuse Reviews Cystathionine β-synthase Induces Multidrug Resistance and Metastasis in Hepatocellular Carcinoma
Current Molecular Medicine Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Roles of NHERF1/EBP50 in Cancer
Current Molecular Medicine An Approach to Treatment of Liver Cancer by Novel Glycyrrhizin Derivative
Anti-Cancer Agents in Medicinal Chemistry Vitamin D and Lung Cancer
Current Respiratory Medicine Reviews The Influence of Lipophilicity on the Classification of Antitumor Acridinones Evaluated by Principal Component Analysis
Current Pharmaceutical Analysis Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Bladder Cancer: A Simple Model Becomes Complex
Current Genomics Cell-Based Assay System to Estimate the Effect of 125I Seeds on Cancer Cells: Effect of Osteopontin
Recent Patents on Anti-Cancer Drug Discovery Radiolabeled Peptide Probes for Liver Cancer Imaging
Current Medicinal Chemistry Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Current Drug Targets Crosstalk between IGF-1R and other Tumor Promoting Pathways
Current Pharmaceutical Design PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts
Current Pharmaceutical Design